Each SPORE is required to include a minimum of 4 translational research projects, each designed to test the relevance and/or potential importance of the research to human cancer within the five-year term of the grant.
Immunotherapy of Pancreatic Adenocarcinoma
Project Leaders: Michael A. Hollingsworth, Ph.D., Jean Grem, M.D.
Inhibitors of N-cadherin in the treatment of pancreatic cancer
Project Leaders: Keith R. Johnson, Ph.D., Jean Grem, M.D.
Biological Marker(s) in the diagnosis of pancreatic cancer
Project Leaders: Surinder Batra, Ph.D., Randall Brand, M.D., and Aaron Sasson, M.D.
Inhibitors of Telomerase in treatment of pancreatic adenocarcinoma
Project Leaders: Michel Ouellette, Ph.D., Jerry Shay, Ph.D., and Jean Grem, M.D.